Results 151 to 160 of about 5,279 (205)

Effectiveness of azvudine versus nirmatrelvir/ritonavir for hospitalized patients with SARS-CoV-2 infection and pre-existing liver diseases. [PDF]

Virol J
Su G, Gao F, Yang M, Wang L, Liang L, Li S, Li G, Han N, Li G, Qian G, Zhang S, Luo H, Zhang D, Liang H, Ren Z.   +14 more
europepmc   +1 more source

Single-dose cathepsin L CRISPR nanotherapy mitigates PASC-like lung damage in hamsters. [PDF]

Nano Res
Cui Z, Liu T, Bacon R, Zhao Y, Everitt JI, Yan J, Chen L, Huang J, Wang H, Dong Y, Jin VX, Liu SL, Wang Q.   +12 more
europepmc   +1 more source

A Lung-Immune Dual-Humanized Mouse Using Cryopreserved Tissue Enables Infection and Immune Profiling of Human Common Cold Coronaviruses. [PDF]

Adv Sci (Weinh)
Cheng C, Sun J, Lu C, Yu Q, He Y, Wu B, Ren D, Ding S, Zhao J, Li Y.   +9 more
europepmc   +1 more source

Could ChatGPT and co. replace forensic experts? A comparative study on medical liability expertise. [PDF]

Int J Legal Med
Bérar A, Allain JS, Bouvet R.
europepmc   +1 more source

Next-generation inhibitors of SARS-CoV-2 M^pro overcome the deficiencies of Paxlovid. [PDF]

Nat Commun
Luo G, Wang G, Liao C, Zhong B, Fan L, Zhang J, Rao J, Zhang J, Wang Z, Luo M, Yan Y, Lu L, Xu W, Wu F, Gao X, Lu W.   +15 more
europepmc   +1 more source

Candidate treatments for long COVID: a narrative review of expert and patient-driven priorities. [PDF]

Front Med (Lausanne)
Baptista SN, Atkins T, Chakraborty S, Bakhit M, Glasziou P, Byambasuren O.   +5 more
europepmc   +1 more source